{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:55:22Z","timestamp":1793904922804,"version":"4.8.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital of Sichuan University","doi-asserted-by":"publisher","award":["2024SCU12022"],"award-info":[{"award-number":["2024SCU12022"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["2024HXBH055"],"award-info":[{"award-number":["2024HXBH055"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102896"],"award-info":[{"award-number":["82102896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1883"],"award-info":[{"award-number":["2024NSFSC1883"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.phymed.2024.156093","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T12:35:10Z","timestamp":1727181310000},"page":"156093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Liposomal honokiol inhibits non-small cell lung cancer progression and enhances PD-1 blockade via suppressing M2 macrophages polarization"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1830-7951","authenticated-orcid":false,"given":"Yuan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintian","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiawei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.156093_bib0001","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.phymed.2024.156093_bib0002","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar3054","article-title":"PD-L1 expression on nonclassical monocytes reveals their origin and immunoregulatory function","volume":"4","author":"Bianchini","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.phymed.2024.156093_bib0003","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2024.156093_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.156093_bib0005","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1038\/s41388-023-02781-9","article-title":"JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3\/IL-10 axis","volume":"42","author":"Chen","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.156093_bib0006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.fsi.2017.02.020","article-title":"Magnolol and honokiol from Magnolia officinalis enhanced antiviral immune responses against grass carp reovirus in Ctenopharyngodon idella kidney cells","volume":"63","author":"Chen","year":"2017","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.phymed.2024.156093_bib0007","first-page":"957","article-title":"Synergistic antitumor effects of liposomal honokiol combined with cisplatin in colon cancer models","volume":"2","author":"Cheng","year":"2011","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phymed.2024.156093_bib0008","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-021-01355-1","article-title":"Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin","volume":"20","author":"Cheng","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2024.156093_bib0009","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/mco2.105","article-title":"Therapeutic advances in non-small cell lung cancer: focus on clinical development of targeted therapy and immunotherapy","volume":"2","author":"Cheng","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.phymed.2024.156093_bib0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/CJI.0b013e3181a8efe6","article-title":"Honokiol-mediated inhibition of PI3K\/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function","volume":"32","author":"Crane","year":"2009","journal-title":"J. Immunother."},{"key":"10.1016\/j.phymed.2024.156093_bib0011","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/CAD.0000000000000771","article-title":"Formylated honokiol analogs showed antitumor activity against lung carcinoma","volume":"30","author":"Deng","year":"2019","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.phymed.2024.156093_bib0012","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1056\/NEJMcibr1906340","article-title":"Predicting tumor response to PD-1 blockade","volume":"381","author":"Ding","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2024.156093_bib0013","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-030-35723-8_8","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment","volume":"1224","author":"Dysthe","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phymed.2024.156093_bib0014","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1021\/acsmedchemlett.6b00238","article-title":"Discovery of a selective phosphoinositide-3-kinase (PI3K)-gamma inhibitor (IPI-549) as an immuno-oncology clinical candidate","volume":"7","author":"Evans","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2024.156093_bib0015","first-page":"11","article-title":"Honokiol eliminates glioma\/glioblastoma stem Cell-Like cells via JAK-STAT3 signaling and inhibits tumor progression by targeting epidermal growth factor receptor","author":"Fan","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phymed.2024.156093_bib0016","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-065X.2008.00662.x","article-title":"Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways","volume":"224","author":"Fife","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.phymed.2024.156093_bib0017","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3389\/fimmu.2017.00961","article-title":"Functional expression of programmed death-ligand 1 (B7-H1) by immune cells and tumor cells","volume":"8","author":"Gibbons Johnson","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2024.156093_bib0018","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2024.156093_bib0019","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2024.156093_bib0020","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/0008-5472.1089.65.3","article-title":"Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity","volume":"65","author":"Hirano","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.156093_bib0021","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/ptr.2472","article-title":"Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models","volume":"22","author":"Hou","year":"2008","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phymed.2024.156093_bib0022","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI99317","article-title":"Contribution of NK cells to immunotherapy mediated by PD-1\/PD-L1 blockade","volume":"128","author":"Hsu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2024.156093_bib0023","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3858\/emm.2008.40.6.617","article-title":"Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity","volume":"40","author":"Hu","year":"2008","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phymed.2024.156093_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107694","article-title":"Combination therapy with PD-1\/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms","volume":"219","author":"Huang","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2024.156093_bib0025","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2024.156093_bib0026","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2407-8-242","article-title":"Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model","volume":"8","author":"Jiang","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phymed.2024.156093_bib0027","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.3748\/wjg.v25.i29.3941","article-title":"Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns","volume":"25","author":"Jiraviriyakul","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phymed.2024.156093_bib0028","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41556-019-0373-7","article-title":"Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms","volume":"21","author":"Kim","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phymed.2024.156093_bib0029","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/SHK.0000000000001021","article-title":"Honokiol increases CD4+ T cell activation and decreases TNF but fails to improve survival following sepsis","volume":"50","author":"Klingensmith","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.phymed.2024.156093_bib0030","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1158\/1078-0432.CCR-10-0333","article-title":"Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors","volume":"16","author":"Leeman-Neill","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.156093_bib0031","doi-asserted-by":"crossref","first-page":"e1036","DOI":"10.1002\/ctm2.1036","article-title":"Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3","volume":"12","author":"Li","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.phymed.2024.156093_bib0032","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-021-00869-w","article-title":"Liposomal Honokiol induces ROS-mediated apoptosis via regulation of ERK\/p38-MAPK signaling and autophagic inhibition in human medulloblastoma","volume":"7","author":"Li","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.phymed.2024.156093_bib0033","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.21037\/atm-21-1836","article-title":"Liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization","volume":"9","author":"Li","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.phymed.2024.156093_bib0034","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejogrb.2008.02.023","article-title":"Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells","volume":"140","author":"Li","year":"2008","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.phymed.2024.156093_bib0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.taap.2016.05.018","article-title":"Honokiol induces autophagic cell death in malignant glioma through reactive oxygen species-mediated regulation of the p53\/PI3K\/Akt\/mTOR signaling pathway","volume":"304","author":"Lin","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phymed.2024.156093_bib0036","article-title":"Targeting PI3Kgamma\/AKT pathway remodels LC3-associated phagocytosis induced immunosuppression after radiofrequency ablation","volume":"9","author":"Liu","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.phymed.2024.156093_bib0037","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1172\/JCI137110","article-title":"Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma","volume":"130","author":"Loeuillard","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2024.156093_bib0038","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1247135","article-title":"The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells","volume":"5","author":"Lu","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.phymed.2024.156093_bib0039","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00432-008-0375-5","article-title":"Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer","volume":"134","author":"Luo","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.phymed.2024.156093_bib0040","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1021\/jm200830u","article-title":"Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship","volume":"54","author":"Ma","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phymed.2024.156093_bib0041","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41419-023-05680-9","article-title":"Honokiol suppresses the aberrant interactions between renal resident macrophages and tubular epithelial cells in lupus nephritis through the NLRP3\/IL-33\/ST2 axis","volume":"14","author":"Ma","year":"2023","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2024.156093_bib0042","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc723","article-title":"Natural products in cancer chemotherapy: past, present and future","volume":"2","author":"Mann","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2024.156093_bib0043","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10753-017-0576-7","article-title":"Therapeutic action of honokiol on postoperative ileus via downregulation of iNOS gene expression","volume":"40","author":"Mihara","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.phymed.2024.156093_bib0044","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.156093_bib0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4062\/biomolther.2018.201","article-title":"Analysis of the expression and regulation of PD-1 protein on the surface of myeloid-derived suppressor cells (MDSCs)","volume":"27","author":"Nam","year":"2019","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.phymed.2024.156093_bib0046","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/s41598-017-01774-5","article-title":"Honokiol inhibits ultraviolet radiation-induced immunosuppression through inhibition of ultraviolet-induced inflammation and DNA hypermethylation in mouse skin","volume":"7","author":"Prasad","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2024.156093_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153647","article-title":"Honokiol: a review of its pharmacological potential and therapeutic insights","volume":"90","author":"Rauf","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.156093_bib0048","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.21.01497","article-title":"First-Line Immunotherapy for Non-Small-Cell Lung Cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2024.156093_bib0049","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12967-018-1563-y","article-title":"Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma","volume":"16","author":"Retseck","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phymed.2024.156093_bib0050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.phymed.2024.156093_bib0051","doi-asserted-by":"crossref","first-page":"57752","DOI":"10.18632\/oncotarget.10759","article-title":"Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors","volume":"7","author":"Song","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2024.156093_bib0052","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay1863","article-title":"Targeted deletion of PD-1 in myeloid cells induces antitumor immunity","volume":"5","author":"Strauss","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.phymed.2024.156093_bib0053","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2024.156093_bib0054","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.1601515","article-title":"Akt signaling pathway in macrophage activation and M1\/M2 polarization","volume":"198","author":"Vergadi","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2024.156093_bib0055","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phymed.2024.156093_bib0056","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2011.03.003","article-title":"Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol","volume":"410","author":"Wang","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phymed.2024.156093_bib0057","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cell.2017.07.024","article-title":"Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade","volume":"170","author":"Wei","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.156093_bib0058","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/eji.201041105","article-title":"Alternative activation of macrophages by IL-4 requires SHIP degradation","volume":"41","author":"Weisser","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.phymed.2024.156093_bib0059","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1002\/ijc.24244","article-title":"Liposomal honokiol inhibits VEGF-d-induced lymphangiogenesis and metastasis in xenograft tumor model","volume":"124","author":"Wen","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2024.156093_bib0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpba.2018.02.033","article-title":"Identification, characterization and HPLC quantification of formulation-related impurities of honokiol, an antitumor natural drug candidate in clinical trials","volume":"153","author":"Wu","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.phymed.2024.156093_bib0061","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/d41573-019-00167-9","article-title":"Immuno-oncology drug development goes global","volume":"18","author":"Xin Yu","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2024.156093_bib0062","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.phymed.2024.156093_bib0063","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1080\/10717544.2017.1303854","article-title":"Honokiol-loaded polymeric nanoparticles: an active targeting drug delivery system for the treatment of nasopharyngeal carcinoma","volume":"24","author":"Yang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phymed.2024.156093_bib0064","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.biomaterials.2017.07.002","article-title":"Liposomal honokiol induced lysosomal degradation of Hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells","volume":"141","author":"Yang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.phymed.2024.156093_bib0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2024.156093_bib0066","doi-asserted-by":"crossref","first-page":"31280","DOI":"10.1074\/jbc.M113.505057","article-title":"Mitochondrial localized Stat3 promotes breast cancer growth via phosphorylation of serine 727","volume":"288","author":"Zhang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2024.156093_bib0067","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7150\/thno.36930","article-title":"Macrophage MSR1 promotes BMSC osteogenic differentiation and M2-like polarization by activating PI3K\/AKT\/GSK3beta\/beta-catenin pathway","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.phymed.2024.156093_bib0068","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2007-08-109678","article-title":"Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease","volume":"111","author":"Zheng","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2024.156093_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.jncc.2022.02.002","article-title":"Cancer incidence and mortality in China, 2016","author":"Zheng","year":"2022","journal-title":"J. National Cancer Center"},{"key":"10.1016\/j.phymed.2024.156093_bib0070","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000207","article-title":"Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery","volume":"8","author":"Zheng","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phymed.2024.156093_bib0071","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcp.2016.12.022","article-title":"Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia","volume":"128","author":"Zhou","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2024.156093_bib0072","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.apsb.2022.07.019","article-title":"Honokiol alleviated neurodegeneration by reducing oxidative stress and improving mitochondrial function in mutant SOD1 cellular and mouse models of amyotrophic lateral sclerosis","volume":"13","author":"Zhou","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.phymed.2024.156093_bib0073","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.lfs.2019.01.046","article-title":"Honokiol induces endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells","volume":"221","author":"Zhu","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2024.156093_bib0074","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/gutjnl-2019-318419","article-title":"Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade","volume":"68","author":"Zhu","year":"2019","journal-title":"Gut"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324007505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324007505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T22:35:58Z","timestamp":1747953358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324007505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":74,"alternative-id":["S0944711324007505"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.156093","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposomal honokiol inhibits non-small cell lung cancer progression and enhances PD-1 blockade via suppressing M2 macrophages polarization","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.156093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156093"}}